Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# SGLT2 HYPE

A project for improving hypertension treatment

## Sitemaps

- [XML Sitemap](https://www.sglt2-hype.eu/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [New perspectives for hypertension treatmen](https://www.sglt2-hype.eu/news/new-perspectives-for-hypertension-treatmen/) - Read how SGLT2 HYPE explores dapagliflozin as a potential treatment option for hypertension and high cardiovascular risk.
- [Video interview introduces the SGLT2-HYPE study](https://www.sglt2-hype.eu/news/video-interview-introduces-the-sglt2-hype-study/) - Watch the DGK interview on SGLT2 HYPE and learn how the study explores new therapeutic options for hypertension and cardiovascular risk.
- [The first publication of the SGLT2 HYPE project is now available in the European Heart Journal (CardioPulse)!](https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehag301/8678780#new_tab) - The article outlines the rationale and design of SGLT2 HYPE, a major trial exploring SGLT2 inhibition for hypertension and cardio-renal protection.
- [Patient Perspectives in the Development of the SGLT2 HYPE Home Blood Pressure App](https://www.sglt2-hype.eu/news/patient-perspectives-in-the-development-of-the-sglt2-hype-home-blood-pressure-app/) - Explore patient perspectives on the SGLT2 HYPE home blood pressure app supporting hypertension monitoring and patient engagement
- [SGLT2 HYPE Holds Its 2nd General Assembly Meeting in Hamburg](https://www.sglt2-hype.eu/events/sglt2-hype-holds-its-2nd-general-assembly-meeting-in-hamburg/) - SGLT2 HYPE partners gathered in Hamburg for the 2nd General Assembly Meeting to discuss progress, collaboration, and next project steps
- [Kick-Off meeting](https://www.sglt2-hype.eu/events/kick-off-meeting/) - SGLT2 HYPE Kicks Off with Momentum: A New Chapter in Hypertension Research Begins
- [New EU-funded Project Aims to Transform Hypertension Treatment](https://www.sglt2-hype.eu/wp-content/uploads/SGLT2_HYPE_PressRelease_Project_ProjectStart_final.pdf#new_tab) - SGLT2 HYPE is a guideline-relevant clinical trial aiming to establish SGLT2 inhibitors as a new standard in high blood pressure therapy, ultimately addressing one of the leading causes of premature mortality in Europe

## Pages

- [Home](https://www.sglt2-hype.eu/) - SGLT2 inhibitors have shown potential in lowering blood pressure and providing organ protection due to pleiotropic effects
- [For Clinicians](https://www.sglt2-hype.eu/clinicians/) - Join the SGLT2 HYPE study: EU-wide Phase III trial testing dapagliflozin for blood pressure, heart, and kidney protection in older adults
- [For Patients](https://www.sglt2-hype.eu/patients/) - All potential participants will undergo a screening visit, including blood pressure measurements, blood tests, & a health questionnaire to confirm eligibility
- [News & Media](https://www.sglt2-hype.eu/news-media/) - Discover how dapagliflozin supports heart and kidney health while reducing high blood pressure in elderly patients
- [Form - Thank you for your registration](https://www.sglt2-hype.eu/contact-us/form-thank-you-for-your-registration/) - [et_pb_section fb_built=”1″ _builder_version=”4.22.2″ _module_preset=”default” background_image=”https://www.powerbaseproject.eu/wp-content/uploads/synergise-asset-03.png” background_size=”custom” background_image_width=”600px” background_position=”top_right” background_horizontal_offset=”10%” background_vertical_offset=”50%” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.22.2″ _module_preset=”_initial” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||15px|||” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Contact Thank you for your registration! [/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] We will follow up with further details shortly. [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
- [Legal Notice & Disclaimer](https://www.sglt2-hype.eu/legal-notice-disclaimer/) - [et_pb_section fb_built=”1″ admin_label=”sectionwithlines section01″ module_class=”sectionwithlines section01″ _builder_version=”4.27.4″ _module_preset=”default” background_image=”https://www.sglt2-hype.eu/wp-content/uploads/svg-bg-001.svg” background_size=”initial” background_position=”top_right” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|desktop” _builder_version=”4.27.4″ _module_preset=”_initial” width_tablet=”95%” width_phone=”” width_last_edited=”on|tablet” custom_padding=”|0%||0%|false|false” custom_padding_tablet=”|0%||0%|false|false” custom_padding_phone=”|0%||0%|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”_initial” header_2_text_color=”#E13B3A” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Legal notice disclaimer Information according to § 5 TMGARTTIC Innovation GmbHOscar-von-Miller-Ring 2980333 Munich Commercial register: HRB 255741Register court: MunichRepresented by:Managing Directors: Marcel Kniest,
- [Privacy protection](https://www.sglt2-hype.eu/privacy-protection-sglt2-hype/) - [et_pb_section fb_built=”1″ admin_label=”sectionwithlines section01″ module_class=”sectionwithlines section01″ _builder_version=”4.27.4″ _module_preset=”default” background_image=”https://www.sglt2-hype.eu/wp-content/uploads/svg-bg-001.svg” background_size=”initial” background_position=”top_right” module_alignment=”center” custom_margin=”||||false|false” custom_padding=”||||false|false” global_colors_info=”{}”][et_pb_row custom_padding_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”_initial” width_tablet=”95%” width_phone=”” width_last_edited=”on|tablet” custom_padding=”|0%||0%|false|false” custom_padding_tablet=”|0%||0%|false|false” custom_padding_phone=”|0%||0%|false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”_initial” header_text_color=”#005D6A” header_2_text_color=”#E13B3A” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″] Privacy protection Knowledge, expertise, and trust are crucial pillars of the service by all group companies affiliated with the
- [Privacy Protection](https://www.sglt2-hype.eu/privacy-protection/) - [et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] Privacy protection Knowledge, expertise, and trust are crucial pillars of the service by all group companies affiliated with the PNO Group holding B.V. We are committed to giving you clarity on how we handle your personal data. PNO operates under
- [Copyright](https://www.sglt2-hype.eu/copyright/) - [et_pb_section fb_built=”1″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] Copyright Images of individuals are the copyright of the photographer or the personal property of the person displayed. Please note: You are welcome to make a link to any of the web pages the project has published on the internet.
- [Contact us](https://www.sglt2-hype.eu/contact-us/) - For further information about the study, you can use the contact form on the website to ask questions directly about the SGLT2 HYPE project
- [About](https://www.sglt2-hype.eu/about/) - International study evaluating the effects of dapagliflozin, an SGLT2 inhibitor, in elderly adults with uncontrolled hypertension at cardiovascular ris
- [Press Releases](https://www.sglt2-hype.eu/press-releases/) - [et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.27.4″ _module_preset=”default” background_enable_color=”off” custom_padding=”||33px|||” custom_padding_tablet=”0px||33px||false|false” custom_padding_phone=”0px||33px||false|false” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” header_text_color=”#005D6A” header_2_text_color=”#E13B3A” width=”100%” width_tablet=”100%” width_phone=”100%” width_last_edited=”on|phone” global_colors_info=”{}”] Press Releases [/et_pb_text][/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][/et_pb_row][/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” disabled_on=”off|off|off” admin_label=”Press Release and News” _builder_version=”4.27.4″ _module_preset=”default” custom_padding=”2px|||||” custom_padding_tablet=”2px||0px||false|false” custom_padding_phone=”2px||0px||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https://www.sglt2-hype.eu/wp-content/uploads/icon-contact.svg”
- [Implementation](https://www.sglt2-hype.eu/about/implementation/) - To achieve its goal SGLT2 HYPE has developed 15 thematic individual but closely connected work packages (WPs)
- [Advisory Board](https://www.sglt2-hype.eu/about/advisory-board/) - You will find here our scientific advisors and ethics advisors from the SGLT2 HYPE project - Shaping the Future of Healthcare
- [The Team](https://www.sglt2-hype.eu/about/the-team/) - Partners from Austria, Czech Republic, France, Germany, Italy, Lithuania, Poland, Portugal, Slovenia, Spain, the United Kingdom, the Netherlands Ukraine
- [Form - Confirmation Expired](https://www.sglt2-hype.eu/contact-us/form-confirmation-expired/) - [et_pb_section fb_built=”1″ _builder_version=”4.22.2″ _module_preset=”default” background_image=”https://www.powerbaseproject.eu/wp-content/uploads/synergise-asset-03.png” background_size=”custom” background_image_width=”600px” background_position=”top_right” background_horizontal_offset=”10%” background_vertical_offset=”50%” global_colors_info=”{}”][et_pb_row _builder_version=”4.22.2″ _module_preset=”_initial” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||15px|||” global_colors_info=”{}”] Contact Confirmation not valid [/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] The verification is only valid for 72 hours. After this time, we will delete your submitted data automatically. You can submit your data again here:
- [Form - Confirmation](https://www.sglt2-hype.eu/contact-us/form-confirmation/) - [et_pb_section fb_built=”1″ _builder_version=”4.22.2″ _module_preset=”default” background_image=”https://www.powerbaseproject.eu/wp-content/uploads/synergise-asset-03.png” background_size=”custom” background_image_width=”600px” background_position=”top_right” background_horizontal_offset=”10%” background_vertical_offset=”50%” global_colors_info=”{}”][et_pb_row _builder_version=”4.22.2″ _module_preset=”_initial” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||15px|||” global_colors_info=”{}”] Contact Confirmation [/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] Thank you very much for your confirmation. [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]
- [Form - Thank You](https://www.sglt2-hype.eu/contact-us/form-thank-you/) - [et_pb_section fb_built=”1″ _builder_version=”4.22.2″ _module_preset=”default” background_image=”https://www.powerbaseproject.eu/wp-content/uploads/synergise-asset-03.png” background_size=”custom” background_image_width=”600px” background_position=”top_right” background_horizontal_offset=”10%” background_vertical_offset=”50%” collapsed=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.22.2″ _module_preset=”_initial” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.22.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”||15px|||” global_colors_info=”{}”] Contact Thank you for completing the form! [/et_pb_text][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] A confirmation email with all the details will be sent to you shortly. [/et_pb_text][/et_pb_column][/et_pb_row][/et_pb_section]

## Categories

- [News](https://www.sglt2-hype.eu/category/news/)
- [Events](https://www.sglt2-hype.eu/category/events/)
- [Press release](https://www.sglt2-hype.eu/category/press-release/)
- [Newsletter](https://www.sglt2-hype.eu/category/newsletter/)
- [Publication](https://www.sglt2-hype.eu/category/publication/)